Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma

Acta Neuropathol Commun. 2017 May 15;5(1):38. doi: 10.1186/s40478-017-0440-x.

Giselle López¹, Nancy Ann Oberheim Bush², Mitchel S Berger³, Arie Perry^{1

3}, David A Solomon^{4

5}

¹ Division of Neuropathology, Department of Pathology, University of California, San Francisco, 513 Parnassus Ave, Health Sciences West 451, Box 0102, San Francisco, CA 94143, CA, USA.
² Division of Neuro-Oncology, Department of Neurological Surgery, University of California, San Francisco, CA, USA.
³ Department of Neurological Surgery, University of California, San Francisco, CA, USA.
⁴ Division of Neuropathology, Department of Pathology, University of California, San Francisco, 513 Parnassus Ave, Health Sciences West 451, Box 0102, San Francisco, CA 94143, CA, USA. [email protected].
⁵ Clinical Cancer Genomics Laboratory, Department of Pathology, University of California, San Francisco, CA, USA. [email protected].

No abstract available

Publication types